Answers are grounded in this paper and cite their sources.
Dear Editor, Mohs micrographic surgery (MMS) is a time‐consuming and expensive gold‐standard treatment for difficult‐to‐treat basal cell carcinoma (BCC). One factor that contributes significantly to the expense and duration is the number of stages required to obtain clear excision margins.1 Dermoscopy is a noninvasive and inexpensive procedure. It has been used principally for the diagnosis of pigmented lesions but is also useful when reviewing BCC.2 We have investigated whether the use of noncontact dermoscopy has an influence on the number of Mohs stages required for tumour clearance. We included 317 patients with head and neck BCCs excised by MMS, of whom 170 were male, 147 female, median age 72 years (range 30–91). Patients were randomized to either loupe‐assisted naked‐eye or noncontact dermoscopy (DermLite DL200 hybrid; DermLite, San Juan Capistrano, CA, U.S.A.) assessment of tumour margins prior to the debulking excision. Consultants and surgical fellows assessed the lesions and performed the surgery. We recorded the tumour clinical subtype, dimensions, anatomical location and histological subtype, and the total number of resection stages required for tumour clearance. Recurrent tumours were excluded. When determining the presence of BCC, the following classical patterns were used: arborizing telangiectasia, maple‐leaf‐like areas, large blue‐grey ovoid nests, ulceration, multiple blue‐grey globules and spoke‐wheel areas. Results were analysed using a Poisson regression model: 244 (77%) of the 317 BCCs were classified by the operator as nodular, 37 (12%) as morphoeic and 23 (7%) as superficial. The mean tumour dimensions were 12 × 9 mm (range 3 × 3 mm to 60 × 46 mm). Figure 1 shows results for the number of stages for dermoscopy vs. naked‐eye examination. Chart illustrating the number of stages required to achieve tumour clearance with naked eye and dermoscopic assessment. A univariate Poisson regression model was fitted with an outcome of number of stages, and the following explanatory variables: use of dermoscopy, clinician seniority, clinical subtype, and histological growth pattern of tumour. There was no statistically significant relationship (P < 0·05) between number of stages and the four variables. A subgroup analysis looking at all types of histological growth pattern of BCC and the use of dermoscopy yielded no statistically significant results, nor did analyses looking at relationships between use of dermoscopy and anatomical location and clinical subtype. Our study has shown that the use of noncontact dermoscopy to identify tumour margins prior to the debulking excision does not reduce the number of stages required in MMS, irrespective of clinician experience, clinical subtype and tumour histological growth pattern. Our findings are similar to those of others.3 Histological types under those we called ‘other’ included adnexal BCC, bowenoid actinic keratosis and a basisquamous variant of BCC. Dermoscopy examination of BCC may identify a range of changes depending on the histological and clinical subtype. Our study failed to show any benefit of dermoscopy across all clinical types. However, it remains possible that a larger sample could demonstrate that the margins of some BCC subtypes might be more easily recognized using dermoscopy. It is possible that there is a difference in operator proficiency with noncontact dermoscopy, although we found no evidence that clinician seniority had an effect on the number of stages required for tumour excision. Reflectance confocal microscopy allows the visualization of skin structures at a cellular level in a horizontal mosaic image. This may speed up tumour excision by permitting more rapid detection of residual BCC in Mohs sections. As yet there is no evidence that it reduces the number of stages. The disadvantages are that adequate training is required to assess the images and the equipment is expensive.4 Dermoscopy has also been shown to have some benefit in lentigo maligna; however, larger studies need to be undertaken to prove that it is associated with a reduction in Mohs stages.5 In summary, we found no evidence that the preoperative use of dermoscopy prior to MMS enhanced the operator's ability to better identify BCC margins and subclinical spread.
No takes yet. Share an insight, caveat, or question.
Jayasekera et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: